Atlas Trials

Comparison of LY686017 With a Marketed Drug in the Treatment of Social Anxiety Disorder

Clinical trial NCT00191022 · COMPLETED

Trial details

NCT number
NCT00191022
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Social Phobia
Start date
2004-12-01
Enrollment
185

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.